Skip Navigation
Department of Health and Human Services
Slide Tray
0 slides

Return to Slide Library


Add Presentation to Slide Tray Presentation:

First- and Second-Generation Antipsychotics for Children and Young Adults

Slide: 43 of 43

What To Discuss With Your Patients and Their Caregivers

  • The role that antipsychotics may play as one component in the broader array of treatments for child and adolescent psychiatric disorders.
  • The ability of both first-generation and second-generation antipsychotics to improve symptoms of psychiatric disorders in children, and the differences in strength of evidence for benefits in particular indications.
  • The risks of neuromotor effects, weight gain, and blood lipid abnormalities, and the evidence about differences in risk among drugs in both classes.
  • The limited evidence about long-term benefits and adverse effects on health and quality of life.